Daily news
Using evidence as the guiding star, the @ducrest Twitter timeline consists of the latest scientific publications in dermatology, cosmetic dermatology, cosmetics and Home-Use devices. Here you will find interesting information gleaned from science and technology sources as well as the lay press.
RT @JBBC: Enabling Community Through Social Media buff.ly/24rgtLS pic.twitter.com/r5KVSmzPom
RT @CAR_UWE: The challenges of looking ‘different’. Our latest podcast with @JRJPartridge @AdultVoices @FaceEquality. Listen: https://t.co/…
RT @LizAtkin: RT @MindMatters2us Art is the greatest tool I have to transform & reimagine #CompulsiveSkinPicking. A daily reprieve https://…
RT @imcasacademy: Watch the entire #anatomy on #cadaver course from #imcas2016 online: ow.ly/Cxn4300X9mp pic.twitter.com/NsRLaQTvhn
RT @CebdNottm: Looking for information about #skinofcolor or #EthnicSkin ? See our new webpage buff.ly/1TUjjJN #EBderm #ebm https:/…
RT @pascalmeier74: The power of social media to help #doctors & #patients |via #BMJ @symplur blogs.bmj.com/bmj/2015/10/02… pic.twitter.com/mfeixsaxxt
RT @CebdNottm: Use Patient Oriented Eczema Measure (POEM buff.ly/24oE7IY) in clinic/for research? Let us know -reply or email CEBD@…
#ASCO16 news about #melanoma #skincancer
Online now: CheckMate064-nivolumab then ipilimumab more beneficial, more tox vs reverse order in #melanoma https://t.co/dpiSm9c5uq #ASCO16
— The Lancet Oncology (@TheLancetOncol) June 4, 2016
#ASCO16 news about #melanoma #skincancer
#keytruda shows some early benefit in some but not all sarcoma patients –Dr D'Angelo #asco16 pic.twitter.com/dtbGrmzhJj
— Eric D Whitman, MD (@Melanoma_doctor) June 5, 2016
#ASCO16 news about #melanoma #skincancer
#ASCO16 Join Arie Crown Th. 2.15PM Pr Robert @GustaveRoussy KEYNOTE-001 Results: 3-y overall survival for pts w/pembro in advanced #melanoma
— GustaveRoussy (@GustaveRoussy) June 6, 2016